Development of a monoclonal antibody to study MARCH6, an E3 ligase that regulates proteins that control lipid homeostasis
Journal of Lipid Research · 2024
DOI: 10.1016/j.jlr.2024.100650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2024. Verfasst von Shimeng Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Antibodies, Monoclonal, Homeostasis, Membrane Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Membrane-associated ring-CH-type finger 6 (MARCH6), also designated as TEB4 or RNF176, is an E3 ligase that is embedded in membranes of the endoplasmic reticulum where it ubiquitinates many substrate proteins to consign them to proteasome-mediated degradation. In recent years, MARCH6 has been identified as a key regulator of several metabolic pathways, including cholesterol and lipid droplet homeostasis, protein quality control, ferroptosis, and tumorigenesis. Despite its importance, there are currently no specific antibodies to detect and monitor MARCH6 levels in cultured cells and animals. Here, we address this deficiency by generating a monoclonal antibody that specifically detects MARCH6 in cultured cells of insect, mouse, hamster, and human origin, as well as in mouse tissues, with minimal cross-reactivity against other proteins. We then used this antibody to assess two properties of MARCH6. First, analysis of mouse tissues with this antibody revealed that the liver contained the highest levels of March6. Second, analysis of five different cell lines with this antibody showed that endogenous levels of MARCH6 are unchanged as the cellular content of cholesterol is varied. This reagent promises to be a useful tool in interrogating additional signaling roles of MARCH6.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX.
- Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX.
- Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address: arun.radhakrishnan@utsouthwestern.edu.
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
- NIAID NIH HHS
- NHLBI NIH HHS
- National Institute of General Medical Sciences
- National Institute of Allergy and Infectious Diseases Division of Intramural Research
- National Heart Lung and Blood Institute
- National Institutes of Health
Zitieren
APA
Xu, S., Donnelly, L., Kober, D. L., Mak, M., & Radhakrishnan, A. (2024). Development of a monoclonal antibody to study MARCH6, an E3 ligase that regulates proteins that control lipid homeostasis. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2024.100650
Vancouver
Xu S, Donnelly L, Kober DL, Mak M, Radhakrishnan A. Development of a monoclonal antibody to study MARCH6, an E3 ligase that regulates proteins that control lipid homeostasis. Journal of Lipid Research. 2024. doi:10.1016/j.jlr.2024.100650
BibTeX
@article{Xu2024,
author = {Xu, Shimeng and Donnelly, Linda and Kober, Daniel L and Mak, Myra and Radhakrishnan, Arun},
title = {Development of a monoclonal antibody to study MARCH6, an E3 ligase that regulates proteins that control lipid homeostasis},
journal = {Journal of Lipid Research},
year = {2024},
doi = {10.1016/j.jlr.2024.100650}
}
EUVIMED